Details for Patent: 11,559,559
✉ Email this page to a colleague
Which drugs does patent 11,559,559 protect, and when does it expire?
Patent 11,559,559 protects GIAPREZA and is included in one NDA.
This patent has thirty-six patent family members in twenty-two countries.
Drugs Protected by US Patent 11,559,559
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-003 | Dec 23, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | INCREASING BLOOD PRESSURE IN A PATIENT HAVING DISTRIBUTIVE SHOCK | ⤷ Sign Up | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-001 | Dec 21, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | INCREASING BLOOD PRESSURE IN A PATIENT HAVING DISTRIBUTIVE SHOCK | ⤷ Sign Up | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-002 | Dec 21, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | INCREASING BLOOD PRESSURE IN A PATIENT HAVING DISTRIBUTIVE SHOCK | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,559,559
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014364528 | ⤷ Sign Up | |||
| Australia | 2020277230 | ⤷ Sign Up | |||
| Brazil | 112016013961 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
